Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement
CzechiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients
PolandExploring Precision Dosing of Infliximab for Patients with Steroid-Resistant Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of Budesonide and Prednisone for Children with Primary IgA Nephropathy
PolandStudy on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease
AustriaStudy on the Safety of Repeated Intra-Arterial Infusion of Mesenchymal Stem Cells for Children and Adolescents with Refractory Epilepsy
SpainStudy of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)
ItalyStudy on Anticoagulation Strategies with Heparin, Enoxaparin, and Argatroban for Patients with Respiratory or Circulatory Failure on ECMO Support
AustriaStudy on the Effects of Escherichia coli Nissle 1917 in Patients with Autoimmune Uveitis
CzechiaStudy on Treating Graves' Eye Disease with Diclofenac or Simvastatin for Patients with Mild to Moderate Symptoms
SwedenStudy on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis
SpainThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
